A detailed history of Bare Financial Services, Inc transactions in Alkermes Plc. stock. As of the latest transaction made, Bare Financial Services, Inc holds 246 shares of ALKS stock, worth $7,143. This represents 0.0% of its overall portfolio holdings.

Number of Shares
246
Previous 172 43.02%
Holding current value
$7,143
Previous $4.92 Million 49.97%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 10, 2025

BUY
$26.13 - $30.46 $1,933 - $2,254
74 Added 43.02%
246 $7.38 Million
Q2 2025

Aug 13, 2025

BUY
$26.59 - $32.65 $2,845 - $3,493
107 Added 164.62%
172 $4.92 Million
Q1 2025

May 12, 2025

BUY
$28.08 - $36.0 $1,825 - $2,340
65 New
65 $2.15 Million

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.77B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Bare Financial Services, Inc Portfolio

Follow Bare Financial Services, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bare Financial Services, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bare Financial Services, Inc with notifications on news.